ClinicalTrials.Veeva

Menu

Ultra-low Dose Chest Computed Tomography: a Rule-out Tool for Community-acquired Pneumonia

H

Hospital Israelita Albert Einstein

Status

Completed

Conditions

Diagnoses Disease
Pneumonia

Treatments

Diagnostic Test: ULDCT
Diagnostic Test: CR

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a randomized study that sought to compare the rule-out capacity and antibiotics prescriptions associated with two different diagnostic imaging strategies (ultra-low-dose chest computed tomography versus chest radiography) in a group of healthy adults presenting to the emergency department (ED) with suspected community-acquired pneumonia (CAP).

Full description

Between October 2017 and December 2018, we prospectively enrolled consecutive adult patients with suspected community-acquired pneumonia based on at least one respiratory symptom and focal auscultatory findings and at least one sign related to infection, for whom no definitive diagnosis was possible by clinical judgment.

Eligible patients were randomly assigned to their imaging evaluation in a 1:1 ratio to either ultra-low-dose chest computed tomography (ULDCT) or the standard evaluation strategy using conventional chest radiography (CR).

This study sought to compare the rule-out capacity and antibiotics prescriptions associated with those two different diagnostic imaging strategies (ULDCT versus CR) in a group of healthy adult patients presenting to the ED with suspected CAP.

Enrollment

237 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected CAP;
  • At least one respiratory symptom (new or increasing cough, expectoration, dyspnea or chest pain) and
  • At least one symptom related to infection (fever ≥ 38°C, chills, sweating, myalgia, mental confusion or headache) and
  • Focal auscultatory findings during physical examinations (crackling rales)
  • No definitive diagnosis possible by clinical judgment.

Exclusion criteria

  • Score in at least one clinical part of the CURB-65 or PSA scores
  • Clinical diagnosis of rhinosinusitis and acute nasopharyngitis and who had already been treated with antimicrobial therapy for this episode of disease
  • pregnancy;
  • the presence of other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, chronic diseases or other chronic airway conditions;
  • diagnosis of congestive heart failure;
  • body mass index (BMI) greater than 30;
  • inability to hold the breath for at least 10 seconds

Trial design

237 participants in 1 patient group

Suspected community-acquired pneumonia patients
Description:
Suspected community-acquired pneumonia patients that will be evaluated by an imaging method
Treatment:
Diagnostic Test: CR
Diagnostic Test: ULDCT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems